Tang Mitosis/Apoptosis ver. II - Dataset (ID:20003)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | Cell Line | Assay compound conc (uM) | Day | Image | Cell count | Interphase count | Apoptotic count | Dead count | Mitotic count | % Interphase | % Apoptotic | % Mitotic | Recorded Plate | Recorded Well | Control Type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE/CA-PJ15 | 1 | | 963 | 904 | 19 | 4 | 36 | 93.87 | 2.39 | 3.74 | 6 | M14 | N | ||
PE/CA-PJ15 | 2 | | 1975 | 1870 | 28 | 0 | 77 | 94.68 | 1.42 | 3.90 | 6 | M14 | N | ||
PE/CA-PJ15 | 3 | | 3439 | 3268 | 57 | 0 | 114 | 95.03 | 1.66 | 3.31 | 6 | M14 | N | ||
Tozasertib | PE/CA-PJ15 | 0.046 | 1 | | 940 | 872 | 24 | 3 | 41 | 92.77 | 2.87 | 4.36 | 6 | M15 | |
Tozasertib | PE/CA-PJ15 | 0.046 | 2 | | 1785 | 1701 | 35 | 0 | 49 | 95.29 | 1.96 | 2.75 | 6 | M15 | |
Tozasertib | PE/CA-PJ15 | 0.046 | 3 | | 3104 | 2881 | 100 | 0 | 123 | 92.82 | 3.22 | 3.96 | 6 | M15 | |
GSK1070916 | PE/CA-PJ15 | 0.046 | 1 | | 637 | 585 | 16 | 10 | 26 | 91.84 | 4.08 | 4.08 | 6 | M16 | |
GSK1070916 | PE/CA-PJ15 | 0.046 | 2 | | 1003 | 932 | 26 | 11 | 34 | 92.92 | 3.69 | 3.39 | 6 | M16 | |
GSK1070916 | PE/CA-PJ15 | 0.046 | 3 | | 1050 | 940 | 95 | 0 | 15 | 89.52 | 9.05 | 1.43 | 6 | M16 | |
Tozasertib | PE/CA-PJ15 | 6.3e-05 | 1 | | 956 | 908 | 19 | 7 | 22 | 94.98 | 2.72 | 2.30 | 6 | M17 | |
Tozasertib | PE/CA-PJ15 | 6.3e-05 | 2 | | 2097 | 1999 | 32 | 0 | 66 | 95.33 | 1.53 | 3.15 | 6 | M17 | |
Tozasertib | PE/CA-PJ15 | 6.3e-05 | 3 | | 3228 | 3099 | 51 | 0 | 78 | 96.00 | 1.58 | 2.42 | 6 | M17 | |
GSK1070916 | PE/CA-PJ15 | 0.046 | 1 | | 823 | 760 | 29 | 2 | 32 | 92.35 | 3.77 | 3.89 | 6 | M18 | |
GSK1070916 | PE/CA-PJ15 | 0.046 | 2 | | 1087 | 1017 | 32 | 9 | 29 | 93.56 | 3.77 | 2.67 | 6 | M18 | |
GSK1070916 | PE/CA-PJ15 | 0.046 | 3 | | 1076 | 980 | 76 | 0 | 20 | 91.08 | 7.06 | 1.86 | 6 | M18 | |
Tozasertib | PE/CA-PJ15 | 6.3e-05 | 1 | | 1104 | 1044 | 28 | 9 | 23 | 94.57 | 3.35 | 2.08 | 6 | M19 | |
Tozasertib | PE/CA-PJ15 | 6.3e-05 | 2 | | 2118 | 1998 | 33 | 23 | 64 | 94.33 | 2.64 | 3.02 | 6 | M19 | |
Tozasertib | PE/CA-PJ15 | 6.3e-05 | 3 | | 3512 | 3376 | 64 | 0 | 72 | 96.13 | 1.82 | 2.05 | 6 | M19 | |
GSK1070916 | PE/CA-PJ15 | 6.3e-05 | 1 | | 1143 | 1079 | 13 | 21 | 30 | 94.40 | 2.97 | 2.62 | 6 | M20 | |
GSK1070916 | PE/CA-PJ15 | 6.3e-05 | 2 | | 2154 | 2008 | 44 | 33 | 69 | 93.22 | 3.57 | 3.20 | 6 | M20 | |
GSK1070916 | PE/CA-PJ15 | 6.3e-05 | 3 | | 3168 | 3044 | 55 | 0 | 69 | 96.09 | 1.74 | 2.18 | 6 | M20 | |
PE/CA-PJ15 | 1 | | 1022 | 965 | 20 | 6 | 31 | 94.42 | 2.54 | 3.03 | 6 | M21 | N | ||
PE/CA-PJ15 | 2 | | 2004 | 1879 | 36 | 0 | 89 | 93.76 | 1.80 | 4.44 | 6 | M21 | N | ||
PE/CA-PJ15 | 3 | | 3618 | 3470 | 75 | 0 | 73 | 95.91 | 2.07 | 2.02 | 6 | M21 | N | ||
GSK1070916 | PE/CA-PJ15 | 6.3e-05 | 1 | | 1084 | 1002 | 36 | 5 | 41 | 92.44 | 3.78 | 3.78 | 6 | M22 |